Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Assessing Gaps in BRAF Testing in Melanoma & Colorectal Cancer in Developing Regions
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Algeria, Argentina, Brazil, Colombia, Iraq, Kuwait, Lebanon, Mexico, Qatar, Saudi Arabia, United Arab Emirates
    Optimizing Telehealth Use in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Internal Medicine Canada
    Improving ATTR Amyloidosis Management in Spain
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease Spain
    2022 Inflammatory Bowel Disease (IBD) Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    2022 IBD Competitive Grant Program
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Establishment of an Appropriate Network of Medical Care and Education for Axial Spondyloarthritis
    Release Date:
    Partner: The Japan Spondyloarthritis Society
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    2022 Hemophilia ASPIRE-Africa Middle East, Asia-Pacific, & Latin America
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    2022 Global Hemophilia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Management of Uterine Fibroids and Endometriosis
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    2022 Fellowship for Inflammatory Dermatological Diseases
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    2022 Rheumatology Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Established Investigators
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Early Career Investigators
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    2022 Rheumatology Competitive Grant Program
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Innovative Digital Health Projects in Oncology
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    BRAF V600-mutant colorectal cancer: disease education and therapy management
    Release Date:
    Partner: Lilly
    Review Process: Pfizer Internal
    Education Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Pneumococcal Disease Prevention
    Release Date:
    Chronic Pain
    Release Date:
    Bacterial Infections
    Release Date:
    Pharmacy Pneumococcal Disease Prevention
    Release Date:
    Smoking Cessation
    Release Date:
    Non-Small Cell Lung Cancer
    Release Date:
    Cardiovascular Risk in Rheumatoid Arthritis
    Release Date:
    Opioid Pain
    Release Date:
    Adult Pneumococcal Disease Prevention
    Release Date:
    Prevention of Stroke in Women
    Release Date:
    Oncology Educational Needs Assessments
    Release Date:
    Extension Grant
    Release Date:
    Appropriate use of Hormone Therapy in Postmenopausal Women
    Release Date:
    Antimicrobial Stewardship
    Release Date:
    Appropriate Immunizations in Rheumatoid Arthritis Patients
    Release Date:
    Adolescent Immunization
    Release Date:
    Chronic Pain Care
    Release Date:
    Advanced Renal Cell Carcinoma
    Release Date:
    Adherence to Medications for Rheumatoid Arthritis
    Release Date:
    HCP Perceptions on Immunization
    Release Date:
    Smoking Cessation Conference
    Release Date:
    Extension Grant - Window 2
    Release Date:
    Barriers to Adult Immunizations
    Release Date:
    Oral Anticoagulants (Pfizer and BMS)
    Release Date:
    Review Process:
    Release Date:
    Review Process:
    Use of PROS in RA
    Release Date:
    Attention-Deficit/Hyperactivity Disorder
    Release Date:
    Symptomatic Vulvovaginal Atrophy in the Postmenopausal Woman
    Release Date:
    Chronic Pain Care Outcomes
    Release Date:
    Chronic Pain Care in the Patient-Centered Medical Home
    Release Date:
    Medication-Overuse Headache (MOH)
    Release Date:
    Reducing Cardiovascular Risk Globally Through Improved Dyslipidemia Awareness and Treatment
    Release Date:
    Community Oncologist Education and Support Systems ‐ Renal Cell Carcinoma and Hematologic Malignancies
    Release Date:
    Disparities in Adult Immunizations
    Release Date:
    Global Bridges Smoking Cessation
    Release Date:
    Advances in Anticoagulation (Pfizer and BMS)
    Release Date:
    Review Process:
    Cardiovascular Risk In Rheumatoid Arthritis
    Release Date:
    Management of Flares in Rheumatoid Arthritis Patients
    Release Date:
    Immunizations in Young Adolescents
    Release Date:
    Pediatric and Adolescent Migraine
    Release Date:
    Enabling Effective Conversations About Menopausal Vasomotor Symptoms
    Release Date:
    Adult Immunization in Low- and Middle-Income Countries
    Release Date:
    Improving Chronic Pain Outcomes
    Release Date:
    Chronic Pain Care- Interprofessional Team
    Release Date:
    Smoking Cessation
    Release Date:
    Patient Care in Rheumatoid Arthritis
    Release Date:
    Chronic Pain Empowerment Platform
    Release Date:
    Disparities in Adult Pneumococcal Vaccination
    Release Date:
    Anticoagulation Education - NVAF or VTE
    Release Date:
    Review Process:
    Transition of Care in VTE
    Release Date:
    Achievement of Treat-to-Target in Rheumatoid Arthritis
    Release Date:
    Improving Care of Chronic Pain- Physician Groups and Health Systems
    Release Date:
    Facilitation of the Diagnosis of Rheumatoid Arthritis
    Release Date:
    Pfizer and NCCN: Metastatic Breast Cancer
    Release Date:
    Pediatric Immunization Series Completion
    Release Date:
    Pfizer and National Psoriasis Foundation (NPF): Plugging the Treatment Gap in Psoriasis and Psoriatic Arthritis
    Release Date:
    Pfizer and International Atherosclerosis Society (IAS): Lipid Management in High-Risk Patients
    Release Date:
    Pfizer and American Academy of Dermatology (AAD): Patient Access to Care
    Release Date:
    Narrowing the Time Gap between Onset of Symptoms and Treatment for Rheumatoid Arthritis
    Release Date:
    Pfizer and Global Bridges at Mayo Clinic: Treating Tobacco Dependence- Europe Program
    Release Date:
    Implementation of MenB Vaccine Recommendations in Older Adolescents/Young Adults
    Release Date:
    Rheumatology Fellowships
    Release Date:
    Release Date:
    Review Process:
    IPI and Pfizer: Device Challenge- System for Dosing and Dispensing Multiparticulate Formulations of Pediatric Drugs
    Release Date:
    Pfizer and American Pain Society: Improving Chronic Pain Care
    Release Date:
    Accelerating Improvements in Medication Optimization
    Release Date:
    Review Process:
    Haemophilia Early Arthropathy Detection with UltraSound (HEAD-US) Protocol for Routine Joint Assessment of Haemophilia Patients
    Release Date:
    Improving Care of Patients with Atrial Fibrillation in Order to Reduce Stroke Risk
    Release Date:
    IGLC_IHI_RFP Accelerating Improvements in Medication Optimization_Re-release
    Release Date:
    Pfizer and Global Healthy Living Foundation: Rheumatoid Arthritis Shared Decision Making
    Release Date:
    Review Process:
    IBD Fellowship RFP 12212016
    Release Date:
    Rheumatology Fellowship
    Release Date:
    Improving the Identification and Management of Adult Growth Hormone Deficiency (AGHD)
    Release Date:
    Improving Health Care Capacity in Immuno-Oncology
    Release Date:
    Strategies to Support Increasing Exercise and Activity in Haemophilia Patients
    Release Date:
    Improving Pediatric ADHD Care – Innovative Implementation of a National Guideline
    Release Date:
    Reducing the Burden of Cardiovascular Disease in Indonesia
    Release Date:
    Shared Management of Psoriatic Arthritis
    Release Date:
    Building Capacity for Tobacco Dependence Treatment in Japan
    Release Date:
    Clinical Pathways in Breast Cancer
    Release Date:
    Quality improvements in the Management of Atopic Dermatitis
    Release Date:
    Review Process:
    Dermatology Fellowship RFP
    Release Date:
    Dermatology Early Career Investigator Quality Improvement Projects
    Release Date:
    Review Process:
    Programs Toward Improving the Quality of Depression Treatment
    Release Date:
    Improving Patient Care in Inflammatory Bowel Disease (IBD) through Shared Decision-Making
    Release Date:
    Review Process:
    Developing Clinical Research and Publication Skills - AfME and EU
    Release Date:
    Review Process:
    Developing Clinical Research and Publication Skills – UK
    Release Date:
    Review Process:
    Inflammatory Bowel Disease Fellowships
    Release Date:
    Improving Health Outcomes in Atopic Dermatitis (AD) through Shared Decision-Making
    Release Date:
    Review Process:
    Patient Decision Aids for Inflammatory Conditions
    Release Date:
    Review Process:
    Improving Assessment and Treatment of Acute Vaso-occlusive Crisis
    Release Date:
    Rheumatology Fellowship
    Release Date:
    Review Process:
    Developing Clinical Research and Publication Skills – UK (Re-release)
    Release Date:
    Review Process:
    Developing Clinical Research and Publication Skills - AfME and EU (Re-release)
    Release Date:
    Review Process:
    Dermatology Fellowship
    Release Date:
    Review Process:
    Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions
    Release Date:
    Review Process:
    Improving the Clinical Management of Uncontrolled Acromegaly
    Release Date:
    Review Process:
    Antimicrobial Stewardship in the Asia-Pacific Region
    Release Date:
    Review Process:
    Lysosomal Storage Disorders Fellowship for Nurse Practitioners
    Release Date:
    Review Process:
    Hemophilia PUP Registry
    Release Date:
    Review Process:
    Quality Improvement Initiatives:Improving Screening and Diagnosis of Atrial Fibrillation and Optimizing Treatment and Management
    Release Date:
    Review Process:
    Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions
    Release Date:
    Review Process:
    Accelerating the Detection, Diagnosis and Initial Treatment of Psoriatic Arthritis
    Release Date:
    Review Process:
    Improving the Identification and Management of Patients with Atrial Fibrillation (AF) and venous thromboembolism (VTE)
    Release Date:
    Review Process:
    Medication Optimization in Primary Care
    Release Date:
    Review Process:
    Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism
    Release Date:
    Review Process:
    Increasing Rates of BRCA Testing in Patients with Breast Cancer
    Release Date:
    Review Process:
    Providing Access to Learning Resources for Nurses in Africa
    Release Date:
    Review Process:
    Increasing Adult Pneumococcal Immunization Rates through AAFP State Chapters
    Release Date:
    Improving Vaccine Utilization and Preventive Health Maintenance in IBD
    Release Date:
    Review Process:
    Supporting Educational Programs for Radical Reform of Pain Treatment in Japan
    Release Date:
    Review Process:
    Improving Pediatric Immunization Care – Innovative Strategies to Improve Childhood Immunization Rates
    Release Date:
    Review Process:
    Rheumatology Nurse Practitioner and Physician Assistant Fellowship
    Release Date:
    Review Process:
    Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process:
    Improving Pneumococcal Immunization of Adults with Immunocompromising Conditions
    Release Date:
    Review Process:
    Efforts for Early Detection of Atrial Fibrillation and Prevention of Cardio Embolic Stroke
    Release Date:
    Review Process:
    Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism
    Release Date:
    Review Process:
    Project CHANGE - Clinical practice oriented cHange solutions towards Active aNd healthy aGEing
    Release Date:
    Review Process:
    QI Initiaitives Focused on Undiagnosed Nonvalvular Atrial Fibrillation (NVAF)
    Release Date:
    Review Process:
    Quality Improvement initiatives optimizing AF and VTE management in Canada
    Release Date:
    Review Process:
    Improving the Management of Patients with Uncontrolled Acromegaly (International Developed Markets)
    Release Date:
    Review Process:
    Pfizer and the National Kidney Foundation: Improving Immunization Rates of Patients with Chronic Kidney Disease Including Dialys
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Albania
    Integrated Approach to Breast Health Equity
    Release Date:
    Review Process:
    Patient Registries In Metastatic Breast Cancer
    Release Date:
    Review Process:
    Improving Patient Care in Tobacco Dependency
    Release Date:
    Review Process:
    Antimicrobial Stewardship in the Latin America Region
    Release Date:
    Review Process:
    Management of Atopic Dermatitis – International Developed Markets
    Release Date:
    Review Process:
    Improving Standard of Care for Chronic AD
    Release Date:
    Review Process:
    NCCN and Pfizer: Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care
    Release Date:
    Review Process:
    Translating the Atopic Dermatitis (AD)
    Release Date:
    Review Process:
    UK Oncology Quality Improvement Grants
    Release Date:
    Review Process:
    Treatment Patterns of CDK 4/6 Inhibitor Utilization in HR+/HER2- Metastatic Breast Cancer
    Release Date:
    Review Process:
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process:
    Vaccines for All: Longevity Unleashed for Everyone (VALUE)
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines Japan
    Breast Cancer Competitive Research Grant Program for Africa, the Middle East, Asia and Latin America Regions
    Release Date:
    Review Process: Expert Review Panel
    Research Oncology All
    Bristol-Myers Squibb/Pfizer Alliance Announce Quality Improvement initiatives optimizing AF and VTE management in Canada
    Release Date:
    Partner:

    Bristol-Myers Squibb

    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process:
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Local Level Educational Grants Program to Increase Awareness and Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Addressing Knowledge Gaps for the Appropriate Use of Biosimilars
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Acromegaly/Growth Hormone Excess Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Growth Hormone Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Efforts for early detection of atrial fibrillation and cardioembolic stroke prevention
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Japan
    Preventing cardiovascular diseases such as venous thromboembolism in cancer patients by raising awareness and promoting medical
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Patient Registries In ATTR-CM
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease Japan
    Optimizing Menopausal Symptom Management in Canada
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    Optimizing Menopausal Symptom Management in Canada
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    Gene and Anti-TFPI Therapies in Hemophilia
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Implementing Updated Pneumococcal Immunization Recommendations in Adults
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines USA
    Biomarker Testing / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Employment support / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Cachexia in Cancer – Educational Needs Assessment (USA, Canada, Japan, Italy, UK, Spain, Germany, France)
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Canada, France, Germany, Italy, Japan, Spain, USA, United Kingdom
    Addressing Knowledge Gaps in the Care of Patients with HR-positive/HER2-negative Advanced Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Hemophilia Research in Africa-Middle East, Asia Pacific, China and Latin America
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Rheumatic diseases such as SLE, SS, SSc, vasculitis syndrome
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Optimal treatment and management of Rheumatoid Arthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Education relating to Etiology, diagnosis, treatment and, management of Spondyloarthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Inflammation ASPIRE Rheumatology: Europe (except Germany), Israel, Turkey, Russia, Australia, New Zealand, Japan and South Korea
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    Inflammation ASPIRE Ulcerative Colitis:Europe (except Germany), Israel, Turkey,Russia,Australia,New Zealand, Japan, South Korea
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All
    Hemophilia: Improve general knowledge level of gene therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) Disorders
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Serotyping of Streptococcus pneumoniae
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Artificial Intelligence/Machine Learning Research in Hemophilia
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Enhancing awareness and well understanding of the management in hypothalamic pituitary dysfunction, growth disorders
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Long-acting Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    2020 Osteoarthritis and Osteoarthritis Pain- Virtual Learning
    Release Date:
    Partner:

    Lilly

    Review Process: Pfizer Internal
    Education Internal Medicine All
    NASH – Future of Non-invasive Diagnosis Technologies
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Pfizer-ISID 2020 AFME Grant Challenge (Africa and the Middle East)
    Release Date:
    Partner:

    International Society for Infectious Diseases (ISID)

    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Advances in Oncology Therapy in Renal Cell Carcinoma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Increasing Awareness of Nuclear Scintigraphy in Cardiac Amyloidosis
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Pfizer and RCNi – Providing Access to Learning Resources for Nurses in the APAC/China Region
    Release Date:
    Partner:

    RCNi (subsidiary of the Royal College of Nursing)

    Review Process: Pfizer Internal
    Education Internal Medicine Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease Argentina, Brazil, Chile, Colombia
    Vaccine Preventable Diseases – COVID-19 (closed early)
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All
    Phase I/II Clinical Trials of Axitinib in the Treatment of Melanoma, Hepatocellular Carcinoma and Colorectal Cancer
    Release Date:
    Partner:

    NCCN

    Review Process: Expert Review Panel
    Research Oncology All, USA
    Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Incorporating Biosimilar Treatment Options in Solid Tumor Education Programs
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    NSCLC – Current Practice Considerations
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Mexico, Monaco, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, USA, United Kingdom
    Gram Negatives Pathogens & Antimicrobial Resistance: Local Data Generation in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Guatemala, Honduras, Mexico, Panama, Peru, Uruguay
    Addressing Health Disparities in Inflammatory Bowel Disease
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology USA
    Enduring SpA Programs
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Atopic Dermatitis Patient Education
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Knowledge Gaps in Updated Pneumococcal Immunization Recommendations
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Prostate Cancer Disparities Project
    Release Date:
    Partner:

    American Cancer Society

    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Telehealth Solutions in Rheumatoid Arthritis for Improving Education and Patient Care (Emerging Markets)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Telehealth Solutions in Atopic Dermatitis for Improving Education and Patient Care (Emerging Markets)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Life-Long Learning and Implementation of Education in Pain Associated with Osteoarthritis (Europe EFIC)
    Release Date:
    Partner:

    Lilly

    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Albania, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, France, Metropolitan, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Moldova, Republic of, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom
    Use of Biosimilar Agents in Inflammatory Conditions
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Diagnosis of Invasive Fungal Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Afghanistan, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territory, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Cocos (Keeling) Islands, Colombia, Comoros, Congo, Congo, The Democratic Republic, Cook Islands, Costa Rica, Cote D'ivoire, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, East Timor, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Falkland Islands (Malvinas), Faroe Islands, Fiji, Finland, France, France, Metropolitan, French Guiana, French Polynesia, French Southern Territories, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guinea, Guinea-bissau, Guyana, Haiti, Heard and Mc Donald Islands, Holy See (Vatican City State), Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Korea, Korea, Democratic People's Rep, Kuwait, Kyrgyzstan, Lao People's Democratic Republ, Latvia, Lebanon, Lesotho, Liberia, Libyan Arab Jamahiriya, Liechtenstein, Lithuania, Luxembourg, Macau, Macedonia, The Former Yugoslav, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Federated States o, Moldova, Republic of, Monaco, Mongolia, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, Netherlands Antilles, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norfolk Island, Northern Mariana Islands, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Puerto Rico, Qatar, Reunion, Romania, Russia, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadin, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Seychelles, Sierra Leone, Singapore, Slovakia (Slovak Republic), Slovenia, Solomon Islands, Somalia, South Africa, South Georgia and the South Sa, Spain, Sri Lanka, St. Helena, St. Pierre and Miquelon, Sudan, Suriname, Svalbard and Jan Mayen Islands, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tajikistan, Tanzania, United Republic of, Thailand, Togo, Tokelau, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States Minor Outlying I, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Virgin Islands (British), Virgin Islands (U.S.), Wallis and Futuna Islands, Western Sahara, Yemen, Yugoslavia, Zambia, Zimbabwe
    Adoption of Biosimilars in Oncology
    Release Date:
    Partner:

    The National Comprehensive Cancer Network® (NCCN)

    Review Process: Expert Review Panel
    Research Oncology USA
    Improving Disparities in Rheumatoid Arthritis Health Care in Post COVID-19 Era in memory of Cinzia Curiale
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
    Management of Non-Communicable Diseases (NCD) for Health Care Providers
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Italy, Japan, Kazakhstan, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Turkey, USA, Ukraine, United Kingdom
    Continuity of Care: Education for Rheumatology Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Assessment of on-time immunization coverage in children under 2 years of age in Canada
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Canada
    Optimal Early Therapy Management in CML
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Canada, USA
    Addressing Racial Disparities in Cancer Care
    Release Date:
    Partner: American Cancer Society
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Addressing Knowledge Gaps in Growth Hormone Deficiency
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Telehealth in Postmenopausal Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFP
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada, USA
    ADVANCE: Global Awards for Advancing Chronic Pain Research
    Release Date:
    Partner: Eli Lilly and Company
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 Era
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology United Kingdom
    New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)
    Release Date:
    Partner: Merck KGaA Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology France, Germany, Italy, Spain, USA, United Kingdom
    Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Remote Mentoring Programs in RCC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)
    Release Date:
    Partner: The Sharing Progress in Cancer Care (SPCC)
    Review Process: Expert Review Panel
    Quality Improvement Oncology All
    Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Canada, USA
    Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    NSCLC Oncogene Driver Considerations in Testing & Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology France, Germany
    Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Pharmacist Education in Biosimilars (Western Europe, Canada, Japan)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Biosimilars in Hematologic Malignancies & Supportive Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Advances in Atopic Dermatitis for Advanced Practitioners
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2020 RD US- Next Generation PET Imaging for ATTR-CM
    Release Date:
    Partner: GE Healthcare
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant Program
    Release Date:
    Partner: International Society of Amyloidosis
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence Treatment
    Release Date:
    Partner: Mayo Clinic/Global Bridges
    Review Process: Expert Review Panel
    Education Internal Medicine China, Malaysia, Taiwan, Thailand
    4th Quality Improvement initiatives optimizing AF and VTE management in Canada
    Release Date:
    Partner: Bristol-Myers Squibb
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Canada
    2021 Rheumatology Competitive Grant Program
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    2021 Ulcerative Colitis Competitive Grant Program
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Adoption of Biosimilars in Oncology
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Canada
    2021 Global Hemophilia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Inflammatory and Immune-Mediated Dermatologic Disorders
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care Professionals
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Understanding Residual Cardiovascular Risk Related to Triglyceride-Rich Remnant Lipoproteins
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Call for Independent Medical Education Grant Applications Oncology – Prostate Cancer
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    I&I REALE 2021 RhEumatoid Arthritis Italian ReaL World Experience
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
    Inflammatory and Immune-Mediated Dermatologic Disorders (Global excluding U.S.)
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    2021 Rheumatology Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    2021 Inflammatory Bowel Disease (IBD) Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    2021 Fellowship for Inflammatory Dermatological Diseases
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    COVID-19 Vaccine Patient Education: Addressing Vaccine Hesitancy
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease Canada
    Quality Improvement Grants to Support the Development of Cardiac Amyloid Centers
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease Canada
    Junior Investigator Transthyretin Amyloid Polyneuropathy (ATTR-PN) Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Junior Investigator Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    2021 Growth Hormone Research (United States)
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Acromegaly
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Pediatric Endocrinology Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Providing Access to Learning Resources for Tobacco Dependence Treatment
    Release Date:
    Partner: Duke University
    Review Process: Expert Review Panel
    Education Internal Medicine Bahrain, Egypt, Kuwait, Oman, Qatar, Saudi Arabia, South Africa, United Arab Emirates
    2021 Global ANGPTL3 ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Inflammatory Bowel Disease (Europe, Israel, Turkey, Russia, Canada, Australia, New Zealand and Japan)
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology All
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Epidemiology of Atopic Dermatitis, Alopecia Areata and Vitiligo Needs Assessment (Asia, Latin America, the Middle East & Africa)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    PCF-Pfizer Health Equity Challenge Awards
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Research Oncology All
    Shared Decision Making Including Financial Cost and Cancer Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Employment Support / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Biomarker Testing / Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Early Identification and Diagnosis of Axial Spondyloarthritis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    BRAF-mutant melanoma: treatment selection and side effect management
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic Embolism
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Japan
    Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Education and Support for Patients with Locally-Advanced or Metastatic Bladder Cancer
    Release Date:
    Partner: Merck KGaA, Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology USA
    Pre-clinical & Translational Research in Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Canada, USA
    Management of Patients with BRAF-mutant metastatic colorectal cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease All
    Promotion of Smoking Cessation Treatment in General Practice
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    2021 Growth Hormone Research (All countries except for the United States)
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain
    Release Date:
    Partner: Lilly
    Review Process: Pfizer Internal
    Education Internal Medicine All
    NSCLC Therapy Management for Optimal Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom
    Clinical Research Capability Development
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine China
    Educational Program to Increase Awareness and Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease China
    Improve the care of patients living with metastatic breast cancer
    Release Date:
    Partner: Rethink Breast Cancer
    Review Process: Expert Review Panel
    Quality Improvement Oncology Canada
    Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Quality Improvement in Pediatric Endocrinology fields
    Release Date:
    Partner: The Japanese Society for Pediatric Endocrinology
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease Japan
    Topical Hemostasis in Minimally Invasive Surgery
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Advances in Immuno-Oncology Therapy in Urothelial Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    IBD Fellow Training in US
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal Cancer
    Release Date:
    Partner: ACCC
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Imaging Diagnostics for Differentiating Cardiac Amyloidosis
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Telemedicine Initiatives for Patients with Suspected Cardiomyopathy of Unknown Cause
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Improving Treatment Environment for Chronic Myeloid Leukemia (CML)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Atrial Fibrillation and Venous Thromboembolism (excluding United States)
    Release Date:
    Partner: BMS
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology France, Germany, Italy, Japan, Spain, United Kingdom
    China Breast Cancer Landscape – Educational Needs Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology China
    Enzalutamide in the Treatment of Prostate Cancer
    Release Date:
    Partner: National Comprehensive Cancer Network, Astellas
    Review Process: Expert Review Panel
    Research Oncology USA
    Education of Healthcare Professionals to Provide Appropriate Medical Care for Patients with Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Japan
    Addressing Primary Immunodeficiencies within Minority/Underserved Populations
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S.
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator Competitive Grant Program
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Patient and Caregiver Awareness of Drug Resistant Infections (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic Diseases
    Release Date:
    Partner: The Japan College of Rheumatology
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    A Quality Improvement Grant Request for Proposals Addressing Social Health Needs in Chronic and Preventative Disease
    Release Date:
    Partner: IHI
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
    Establishment of Support System for Healthy Life Extension of Patients with CV disease
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Japan
    Racial and Ethnic Disparities in the Menopause Experience
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Immunotherapy in Urothelial Carcinoma
    Release Date:
    Partner: Merck KGaA Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology All
    Managment of Metabolic Risks that Drive Liver Diseases and Increase Cardiovascular Risk in NASH
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    NSCLC Biomarker Testing
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom
    Development of Talazoparib for Prostate Cancer
    Release Date:
    Partner: National Comprehensive Cancer Network
    Review Process: Expert Review Panel
    Research Oncology USA
    Approaches to Smoking Cessation Counseling
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Australia, India, Japan, New Zealand, Singapore, Taiwan
    Burden of Community Acquired Pneumonia
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines USA
    Closing Knowledge Gaps in Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Progress in Androgen Deprivation Therapy (ADT) in Advanced Prostate Cancer
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Oncology USA
    Efforts to Promote Team-based Care and Regional Medical Collaboration for Cancer Patients
    Release Date:
    Partner: Japan Society of Clinical Oncology
    Review Process: Expert Review Panel
    Quality Improvement Oncology Japan
    ISID-Pfizer 2021 Grant Challenge
    Release Date:
    Partner: The International Society for Infectious Diseases (ISID)
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Hemophilia: Improve Knowledge Level of Gene Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Data generation on the treatment of Metastatic Breast Cancer with CDK 4/6 inhibitors
    Release Date:
    Review Process: Expert Review Panel
    Research Oncology Portugal
    China Medical Education in Breast Cancer Diagnosis and Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology China
    COVID-19 Epidemiology Research
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Algeria, Egypt, Indonesia, Lebanon, Philippines, Thailand, Tunisia, Vietnam
    Understanding Healthcare disparities in IBD Patients in Underserved Communities
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada, USA
    Latin America Needs Assessment of Mental Health
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Mayo Clinic
    Review Process: Expert Review Panel
    Translation: French (link)
    Translation: Spanish (link)
    Translation: Mandarin (link)
    Translation: Arabic (link)
    Quality Improvement Rare Disease All
    Identifying and Diagnosing Juvenile Idiopathic Arthritis (JIA)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Antibiotic Stewardship in Pediatrics
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital All
    China Educational Needs Assessment in Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China
    China Medical Education in Atopic Dermatitis Awareness and Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China
    Educational Activities to Improve Vaccination Rate beyond Clinical Departments
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)Emerging Markets (Asia, Latin America, Africa, and Middle East)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Improving the Knowledge Gap on Vaccine Safety Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Promotion of the Appropriate Diagnosis and Treatment of Pediatric Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Improve the Treatment Environment for Cancer Pain Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Promoting Pain Treatment in Osteoarthritis Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Appropriate Immunization among Patients with Immune-Mediated Inflammatory Diseases (IMIDs)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology All
    Developing Clinical Research and Publication Skills(Asia, AfME, Latin America and China)
    Release Date:
    Partner: British Medical Journal (BMJ)
    Review Process: Expert Review Panel
    Education Internal Medicine All
    A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color
    Release Date:
    Partner: Conquer Cancer, The ASCO Foundation
    Review Process: Expert Review Panel
    Research Oncology USA
    PCF-Pfizer-Myovant Relugolix Challenge Awards
    Release Date:
    Partner: The Prostate Cancer Foundation and Myovant Sciences GmbH
    Review Process: Expert Review Panel
    Research Oncology USA
    BRAF-mutation Biomarker Testing in Colorectal Cancer and Melanoma
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Oncology Canada
    Pfizer Innovation Challenge: Patient Preference Database Blueprint
    Release Date:
    Review Process: Expert Review Panel
    Research Support for the Professions All
    Management of Uterine Fibroids and Endometriosis
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    COVID-19 Impact and SARS-CoV-2 Viral Lifecycle
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Addressing Knowledge Gaps on Biosimilar Use in Inflammatory Conditions
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Dermatology Research Fellowship in Skin of Color
    Release Date:
    Partner: Skin of Color Society
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    NSCLC Therapy Management for Optimal Outcomes(Asia, Africa, Middle East, Latin America)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    Cardiac Transthyretin Amyloid (ATTR) Fellowship
    Release Date:
    Partner: International Society of Amyloidosis
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital All
    Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Emerging Markets Asia
    Release Date:
    Partner: RCNi
    Review Process: Expert Review Panel
    Education Support for the Professions Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Improving Real-World Evidence & Data Generation Skills in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Education Support for the Professions All
    Optimizing Venous Thromboembolism Management in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine All
    Alopecia Areata, Atopic Dermatitis and Vitiligo (Global)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited Settings
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Increase HCP knowledge of Gene Therapy management
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease China
    Burden of Pneumococcal Disease - Analyzing Local Surveillance Data (Asia, Africa, Latin America, and Middle East)
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All
    Pre-clinical & Translational Research in Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Best Practices in HR+HER2-Metastatic Breast Cancer Medical Management Latin America,Africa,Middle East,Asia Pacific except China
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Acute Lymphoblastic Leukemia Peer-to-Peer Education & Support
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Patient Access to CDK 4/6 Inhibitors in the Armamentarium Against Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Understanding healthcare disparities in Atopic Dermatitis and Alopecia Areata patients
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology All
    ADVANCE: Global Awards for Advancing Chronic Pain Research
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Enhancing the Understanding of Health Maintenance in the Management of IBD
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Outpatient Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Tajikistan, Turkey, Turkmenistan, Ukraine, United Kingdom, Uzbekistan
    Emerging Therapies in Alopecia Areata for Dermatologists - United States
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Virtual Programs for Rheumatology Education
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2021/2022 Global NASH ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Addressing Knowledge Gaps in Alopecia Areata and Atopic Dermatitis (Global (excluding the US)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    2021/2022 Global Obesity ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Advances in Atopic Dermatitis for Dermatologists and Allergists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Geriatric Anorexia – Educational Needs Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    2021/2022 Global Cachexia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Closing Knowledge Gaps in Moderate-to-Severe Atopic Dermatitis for Allergists
    Release Date:
    Partner: American College of Allergy, Asthma & Immunology (ACAAI)
    Review Process: Expert Review Panel
    Education Inflammation & Immunology USA
    Emerging Therapies for Atopic Dermatitis and Alopecia Areata for Advanced Practice Providers and Primary Care Physicians
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Pediatric Growth Hormone Deficiency Education
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    2021 I&I RE-CUP-IT REal world data Competitive grant in Ulcerative colitis Program - ITalian experiences
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
    Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Cardiac Amyloidosis Mentor mATTch pRogram
    Release Date:
    Partner: Amyloidosis Foundation
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Antimicrobial Stewardship (AMS) Programs in USA, Europe, Japan, South Korea, Australia and New Zealand
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Astellas and Pfizer Call for Independent Medical Education Grant Applications Oncology – Prostate Cancer
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Equity in Access to Rare Disease Clinical Trials
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Management of Endometriosis
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Internal Medicine USA